Project Grant R21MH135128

Award Date 8/1/24
Completion Date 7/31/26
Dollars Obligated $245K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
This $5.1 million project grant from the National Institute of Mental Health (NIMH), part of the Department of Health and Human Services, supports research under the Mental Health Research Grants program (CFDA 93.242). The Massachusetts General Hospital will utilize its existing biobank of over 800 maternal blood and neonatal cord blood samples linked to clinical records to characterize the impact of maternal SARS-CoV-2 infection on fetal neurodevelopment. Researchers will analyze immune...
This federal Project Grant award, valued at $888,632.00 and issued by the Defense Health Agency, supports research conducted by The General Hospital Corporation (doing business as Massachusetts General Hospital) to investigate the role of maternal autoantibodies in inducing behavioral abnormalities in offspring following maternal TLR7 activation. The research, which aligns with the objectives of the Military Medical Research and Development (CFDA 12.420) federal grant program, aims to advance...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This $444,125 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to investigate the role of serotonergic neurons in alterations to adult social behavior following early life adversity. The research team at George Washington University will use the limited bedding and nesting model of early life adversity in mice to study the links between early experience, the serotonergic system, and...
This $742,484 federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 - Mental Health Research Grants will support research to characterize a genetic mouse model and delineate its function in the brain. The project aims to obtain multi-omic single-nucleus RNA sequencing and ATAC-seq data to analyze and correlate gene expression and chromatin modifications in the mouse brain at three critical developmental time points and two key brain regions....
This is a Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) for the project titled "EARLY LIFE STRESS AND DIFFERENTIAL EFFECTS ON THE MOLECULAR MATURATION OF SPECIFIC SUBTYPES OF BRAIN SEROTONIN NEURONS". The $466,125 grant was awarded on August 25, 2023 to President And Fellows Of Harvard College, acting through the Harvard Medical School Division, to investigate the impact of early life stress and...
This federal Project Grant award, valued at $175,647.00 and awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to investigate the relationship between positive childhood experiences, prenatal biobehavioral resilience, and postpartum mental health and well-being. The key objectives of this 5-year project are to: 1) examine how positive childhood experiences are associated with physiological and self-reported...
This federal Project Grant award of $606,029.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the neurocircuitry underlying motivated reward-seeking behavior in response to stress. The key goals of the research are to: 1) Determine if a subpopulation of GABAergic neurons in the medial habenulo-interpeduncular (MHB-IPN) axis...
This Project Grant award from the National Institute of Mental Health (NIMH), under the CFDA 93.242 Mental Health Research Grants program, provides $183,663 in funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on the genetic architecture of neuropsychiatric disorders (NPDs) including autism spectrum disorder (ASD), epilepsy, and schizophrenia. The key objectives of this 4-year research project are to: 1) Apply a rare...
This federal Project Grant award of $715,999.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research by Yale University to investigate the role of microglial TREM2 in mediating the effects of early life adversity and enrichment on hippocampal synaptic development and cognitive function. The research aims to determine if overexpression of TREM2 can correct synaptic and cognitive abnormalities in mice exposed to...

The National Institute of Mental Health (NIMH) awarded a $245,475 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on defining the neuro-immune and placental profile of a dual-hit Toll-Like Receptor 7 (TLR7) and stressor mouse model.

The key objectives of this 2-year research project are to determine whether prenatal TLR7 stimulation induces maternal, placental, and offspring brain inflammatory responses in a sex-biased manner, and to assess whether microglial morphological alterations and pruning of excitatory neurons in specific brain regions are induced by the combination of prenatal TLR7 stimulation and early postnatal resource deprivation stress. This research aims to enhance the understanding of how maternal immune activation and early-life adversity interact to impact neurodevelopment and increase susceptibility to neuropsychiatric disorders.

Generated 7/1/25, 3:17 AM